MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm15197524

Медицинская библиотека · Journal of clinical medicine · 2026

Depression and Anxiety in Melanoma Patients and Their Relationships with Dermatology-Related Quality of Life: A Prospective Observational Cross-Sectional Study.

Hrynczyszyn Maja, Świetlicka Michalina, Piesch Paulina, Krężel Maciej, Adamska Hanna, Buława Inga, Szepietowska Marta, Krajewski Piotr K, Pacan Przemysław, Kamińska-Winciorek Grażyna, Ziętek Marcin, Matusiak Łukasz, Szepietowski Jacek C

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

Patients with melanoma may experience depression and anxiety, but their relationship with dermatology-related quality of life (QoL) remains insufficiently characterized. This study assessed depressive and anxiety symptoms and their associations with QoL, sex, disease stage, and time since diagnosis.

Methods

This cross-sectional study included 162 adults with histologically confirmed melanoma recruited consecutively at two Polish tertiary oncology centers. Participants completed the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Hospital Anxiety and Depression Scale (HADS), and Dermatology Life Quality Index (DLQI). Associations were examined using non-parametric tests and multivariable linear regression.

Results

Positive screening rates were 8.8% for depression using PHQ-9 and 15.2% using HADS-D, and 19.1% for anxiety using GAD-7 and 27.4% using HADS-A. Women had higher PHQ-9, GAD-7, and HADS-A scores than men. All psychological measures correlated with DLQI scores (Spearman's ρ = 0.328-0.414; all adjusted q < 0.001). In multivariable models, higher DLQI scores independently correlated with greater symptom severity across all four measures (all p ≤ 0.001). Female sex independently correlated with higher PHQ-9 and GAD-7 scores, while younger age correlated with higher PHQ-9, GAD-7, and HADS-A scores. Neither melanoma stage nor time since diagnosis was independently associated with psychological symptoms.

Conclusions

Depressive and anxiety symptoms are clinically relevant in melanoma and closely associated with poorer dermatology-related QoL. Psychological screening should not be limited to patients with advanced disease. Females and younger patients may warrant particular attention.

Для цитирования: Hrynczyszyn Maja, Świetlicka Michalina, Piesch Paulina, Krężel Maciej, Adamska Hanna, Buława Inga, Szepietowska Marta, Krajewski Piotr K, Pacan Przemysław, Kamińska-Winciorek Grażyna, Ziętek Marcin, Matusiak Łukasz, Szepietowski Jacek C. Depression and Anxiety in Melanoma Patients and Their Relationships with Dermatology-Related Quality of Life: A Prospective Observational Cross-Sectional Study.. Journal of clinical medicine. 2026. DOI: 10.3390/jcm15197524.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.